Literature DB >> 14530314

Regulation of developing B cell survival by RelA-containing NF-kappa B complexes.

Maria Prendes1, Ye Zheng, Amer A Beg.   

Abstract

Mice deficient in the RelA (p65) subunit of NF-kappaB die during embryonic development. Fetal liver (FL) hemopoietic precursors from these mice were used to generate RelA-deficient lymphocytes by adoptive transfer into lethally irradiated mature lymphocyte-deficient recombination-activating gene-1(-/-) mice. Strikingly, RelA(-/-) lymphocyte generation was greatly diminished compared with that of RelA(+/+) lymphocytes. The most dramatic reduction was noticed in the numbers of developing B cells, which were considerably increased when RelA(-/-) FL cells that were also TNFR1 deficient were used. The role of RelA was further investigated in FL-derived developing B cells in vitro. Our results show that RelA is a major component of constitutive and TNF-alpha-induced kappaB site-binding activity in developing B cells, and provide evidence for a direct role of TNF-alpha in killing RelA(-/-) B cells. The absence of RelA significantly reduced mRNA expression of the antiapoptotic genes cellular FLICE-inhibitory protein and Bcl-2. Retroviral transduction of RelA(-/-) B cells with either cFLIP or Bcl-2 significantly reduced TNF-alpha killing. Together, these results indicate that RelA plays a crucial role in regulating developing B cell survival by inhibiting TNF-alpha cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530314     DOI: 10.4049/jimmunol.171.8.3963

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

3.  NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.

Authors:  Tatiana Kisseleva; Li Song; Marina Vorontchikhina; Nikki Feirt; Jan Kitajewski; Christian Schindler
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

4.  Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells.

Authors:  P Ramakrishnan; D A Kahn; D Baltimore
Journal:  Cell Death Differ       Date:  2010-12-17       Impact factor: 15.828

Review 5.  A single NFκB system for both canonical and non-canonical signaling.

Authors:  Vincent Feng-Sheng Shih; Rachel Tsui; Andrew Caldwell; Alexander Hoffmann
Journal:  Cell Res       Date:  2010-11-23       Impact factor: 25.617

6.  Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function.

Authors:  Sarah J Stein; Albert S Baldwin
Journal:  Blood       Date:  2013-05-13       Impact factor: 22.113

7.  Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases.

Authors:  B O Ibe; M F Abdallah; A M Portugal; J U Raj
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

8.  Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.

Authors:  Nandini Arunkumar; Chaohong Liu; Haiying Hang; Wenxia Song
Journal:  Cell Mol Immunol       Date:  2013-06-03       Impact factor: 11.530

9.  RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.

Authors:  Sergio Vaira; Trevor Johnson; Angela C Hirbe; Muhammad Alhawagri; Imani Anwisye; Benedicte Sammut; Julie O'Neal; Wei Zou; Katherine N Weilbaecher; Roberta Faccio; Deborah Veis Novack
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

10.  Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.

Authors:  Laurie T Krug; Janice M Moser; Shelley M Dickerson; Samuel H Speck
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.